Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Reply: Differentiated Thyroid Carcinoma: Is There Any Evidence for the Use of Recombinant Human TSH in Thyroid Hormone–Secreting Metastasis?

Douglas Van Nostrand
Journal of Nuclear Medicine August 2012, 53 (8) 1330; DOI: https://doi.org/10.2967/jnumed.112.106617
Douglas Van Nostrand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 53 no. 8 1330
DOI 
https://doi.org/10.2967/jnumed.112.106617
PubMed 
22661533

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 1, 2012.

Article Versions

  • previous version (June 1, 2012 - 05:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2012 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2012 to April 2025

AbstractFullPdf
Jun 20120039
Jul 2012009
Aug 201203733
Sep 201201528
Oct 2012013
Nov 2012042
Dec 2012016
Jan 2013047
Feb 20130118
Mar 201301110
Apr 2013098
May 201301911
Jun 2013052
Jul 2013023
Aug 20130116
Sep 2013051
Oct 2013052
Nov 2013021
Dec 2013035
Jan 2014020
Feb 2014035
Mar 2014011
Apr 2014031
May 20140103
Jun 2014061
Jul 2014063
Aug 2014050
Sep 20140122
Oct 20140102
Nov 2014040
Dec 2014040
Jan 2015063
Feb 2015042
Mar 20150173
Apr 2015060
May 20150132
Jun 2015010
Jul 2015054
Aug 2015031
Sep 2015071
Oct 2015050
Nov 2015051
Dec 2015071
Jan 20160117
Feb 201601311
Mar 20160127
Apr 2016080
May 2016051
Jun 2016040
Jul 2016030
Aug 2016060
Sep 2016041
Oct 20160612
Nov 2016041
Dec 20160100
Jan 2017090
Feb 2017061
Mar 2017032
Apr 2017071
May 2017002
Jun 2017060
Aug 2017011
Sep 2017021
Oct 2017073
Nov 2017030
Dec 2017080
Jan 2018040
Feb 2018032
Mar 2018040
Apr 2018040
May 2018040
Jun 2018030
Jul 2018020
Aug 2018040
Sep 2018060
Oct 2018020
Nov 2018041
Dec 2018012
Jan 2019030
Feb 2019032
Mar 2019063
Apr 2019043
May 2019043
Jun 2019032
Jul 2019023
Aug 2019033
Sep 2019030
Oct 2019053
Nov 2019033
Dec 2019040
Jan 2020042
Feb 2020040
Mar 2020021
Apr 2020011
May 2020012
Jun 2020021
Jul 2020021
Aug 2020020
Sep 2020021
Oct 2020021
Nov 2020021
Dec 2020030
Jan 2021032
Feb 2021053
Mar 2021062
Apr 2021030
May 2021082
Jun 20210123
Jul 2021088
Aug 20210104
Sep 2021052
Oct 202101017
Nov 202101016
Dec 2021094
Jan 2022060
Feb 2022060
Mar 2022077
Apr 2022030
May 20220911
Jun 2022064
Jul 20220142
Aug 2022044
Sep 2022046
Oct 2022056
Nov 2022070
Dec 2022091
Jan 2023083
Feb 2023075
Mar 2023060
Apr 20230100
May 2023074
Jun 2023030
Jul 202301110
Aug 20230110
Sep 2023013
Oct 2023024
Nov 2023024
Dec 2023091
Jan 2024041
Feb 2024022
Mar 2024070
Apr 20240142
May 20240121
Jun 20240132
Jul 2024034
Aug 2024098
Sep 20240410
Oct 2024013
Nov 2024047
Dec 20240131
Jan 2025013
Feb 20250302
Mar 202501317
Apr 20250916
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (8)
Journal of Nuclear Medicine
Vol. 53, Issue 8
August 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reply: Differentiated Thyroid Carcinoma: Is There Any Evidence for the Use of Recombinant Human TSH in Thyroid Hormone–Secreting Metastasis?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reply: Differentiated Thyroid Carcinoma: Is There Any Evidence for the Use of Recombinant Human TSH in Thyroid Hormone–Secreting Metastasis?
Douglas Van Nostrand
Journal of Nuclear Medicine Aug 2012, 53 (8) 1330; DOI: 10.2967/jnumed.112.106617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reply: Differentiated Thyroid Carcinoma: Is There Any Evidence for the Use of Recombinant Human TSH in Thyroid Hormone–Secreting Metastasis?
Douglas Van Nostrand
Journal of Nuclear Medicine Aug 2012, 53 (8) 1330; DOI: 10.2967/jnumed.112.106617
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Reply to “The Randomized, Phase 2 LuCAP Study”
  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire